When the Wnt ligand, Wnt-3a, was added to either B-ALL cell lines (NALM6, REH, LK63) or a B-ALL patient sample (0407), β-catenin levels were increased as shown through Western blotting, resulting in significant increases in cell proliferation. This evidence concerns the gene WNT3A and acute lymphoblastic leukemia.